GBP5 Antibody (YA8130)

(Synonyms: GBP-5)
Customer Review

Based on 1 Customer Validation

GBP5 Antibody (YA8130) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to GBP5.

For research use only. We do not sell to patients.
  • Host:

    Mouse

  • Isotype:

    IgG1

  • Application:

    WB, ICC/IF, FC

  • Reactivity :

    Human

  • Formulation:

    Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

  • Conjugation:
    Non-conjugated

Applications

Application
WB Info
WB: Western Blot
ICC/IF Info
ICC/IF: Immunocytochemistry/
Immunofluorescence
FC Info
FC: Flow Cytometry
Dilution Ratio 1:2000-3000 1:100-250 1:100

Product Details

Description

GBP5 Antibody (YA8130) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to GBP5.

  • Host Mouse
  • Clonality Monoclonal
  • Species Reactivity
    Human
  • Calculated Molecular Weight Predicted band size: 66.4 kDa
Immunogen

Full length human recombinant protein of human GBP5 produced in HEK293T cell.

Sensitivity

Endogenous

Purification

Affinity purified

Conjugation

Non-conjugated

Modification

Unmodified

Isotype

IgG1

Product Properties

  • Appearance

    Liquid

  • Formulation

    Spplied in PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.

  • Concentration

    Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration

  • Storage & Stability

    Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

  • Shipping

    Shipping with blue ice.

Background

  • Function

    GBP5 is an Interferon (IFN)-inducible GTPase that plays important roles in innate immunity against a diverse range of bacterial, viral and protozoan pathogens. Hydrolyzes GTP, but in contrast to other family members, does not produce GMP. Following infection, recruited to the pathogen-containing vacuoles or vacuole-escaped bacteria and acts as a positive regulator of inflammasome assembly by promoting the release of inflammasome ligands from bacteria. Acts by promoting lysis of pathogen-containing vacuoles, releasing pathogens into the cytosol. Following pathogen release in the cytosol, promotes recruitment of proteins that mediate bacterial cytolysis: this liberates ligands that are detected by inflammasomes, such as lipopolysaccharide (LPS) that activates the non-canonical CASP4/CASP11 inflammasome or double-stranded DNA (dsDNA) that activates the AIM2 inflammasome. As an activator of NLRP3 inflammasome assembly: promotes selective NLRP3 inflammasome assembly in response to microbial and soluble, but not crystalline, agents. Independently of its GTPase activity, acts as an inhibitor of various viruses infectivity, such as HIV-1, Zika and influenza A viruses, by inhibiting FURIN-mediated maturation of viral envelope proteins |Antigenic tumor-specific truncated splice form[1][2][3][4].

  • Subcellular Localization

    Cytoplasmic vesicle membrane,Golgi apparatus membrane,Cytoplasm

  • Expression


    Tissue_Specificity: Expressed in peripheral blood monocytes (at protein level)
    Induction: By IFNG in endothelial cells and in LPS-primed macrophages

  • Isoforms & Post-Translational Modification

    Q96PP8 has two isomers: Q96PP8-1: 66617 Da (predicted); Q96PP8-2: 55247 Da (predicted).
    Isoprenylation is required for proper subcellular location

  • Subunit

    Homodimer; homodimerizes upon GTP-binding, forming a close face-to-face dimer (PubMed:20180847, PubMed:21151871, PubMed:33876762)

  • SwissProt ID

    Q96PP8

  • Synonyms

    GBP-5

GBP5 Antibody (YA8130) Related Classifications

MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00